Background: Radiotheragnostics makes use of the same molecular targeting vectors, labeled either with a diagnostic or therapeutic radionuclide, ideally of the same chemical element. The matched pair of scandium radionuclides, 44 Sc and 47 Sc, satisfies the desired physical aspects for PET imaging and radionuclide therapy, respectively. While the production and application of
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Background
Over the past few years, the concept of personalized medicine, where patient treatment is performed according to an individually tailored treatment regime, has gained much recognition (Kraeber-Bodere and Barbet 2014). In nuclear medicine, this approach is realized by exploiting diagnostic techniques, such as non-invasive imaging by means of Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT), together with individualized radiotherapeutic treatment (Velikyan 2012) . The resulting combination became known as the theragnostic approach and comprises the use of the same molecular targeting vectors, labeled either with a diagnostic or therapeutic radionuclide (Baum and Kulkarni 2012) . Ideally, the employed radionuclides represent a matched pair, where both are radioisotopes of the same chemical element. Only a limited number of matching radionuclides entail suitable decay characteristics for radiotheragnostic application (Rösch and Baum 2011) ; of those the radionuclides of scandium, 44 Sc/ 43 Sc and 47 Sc, are interesting candidates.
Based on the physical and chemical characteristics, the β − -emitter 47 Sc is particularly interesting for radionuclide therapy, while the decay characteristics of 44 Sc and 43 Sc are wellsuited for diagnostic PET imaging (Table 1) (Rösch 2012; Müller et al. 2014a Müller et al. , 2014b Walczak et al. 2015) .
This matched pair would present an attractive alternative to 68 Ga and 177 Lu, which are currently used in clinics for PET imaging and therapy, respectively (Oh et al. 2011) . Ga(III) and Lu(III) can be coordinated by 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-complexes (Majkowska-Pilip and Bilewicz 2011), however, they do not share the same coordination chemistry. Lu(III) is coordinated by all carboxyl groups of the octadentate DOTA (Viola-Villegas and Doyle 2009; Parus et al. 2015) , while Ga(III) has a preference for the coordination number six, leaving two uncoordinated carboxyl groups in the Ga-DOTA-complex (Viola-Villegas and Doyle 2009; Majkowska-Pilip and Bilewicz 2011). As a result, these structural differences may have an influence on the radioconjugate's chemical properties and, consequently, on the in vivo kinetics and receptor binding affinity (Reubi et al. 2000; Majkowska-Pilip and Bilewicz 2011) . By using chemically identical radionuclides such as 44 Sc/ 47 Sc-known to form stable complexes with DOTA-this limitation could be addressed. The physical half-life of 44 Sc of 3.97 h (recently re-determined as 4.04 h (Garcia-Torano et al. 2016) , is almost 4-fold longer than that of 68 Ga (T 1/2 = 68 min) and, hence, allows its use with biomolecules with slower kinetics. Due to the possibility of shipping 44 Sc-radiopharmaceuticals over long distances, it can also facilitate logistics as it would allow centralized production and distribution to remote hospitals (Chakravarty et al. 2014; van der Meulen et al. 2015) . The increased availability of 44 Sc has initiated a number of preclinical in vitro and in vivo studies with DOTA-conjugated biomolecules (Müller et al. 2013a (Müller et al. , 2013b Hernandez et al. 2014) and, recently, labeling of NODAGA (1,4,7-triazacyclononane,1-glutaric acid-4,7-acetic acid)-functionalized peptides and DTPA (N-[(R)-2-amino-3-(para-isothiocyanato-phenyl)propyl]trans-(S,S)-cyclohexane-1,2-diamine N,N,N' ,N"N"-pentaacetic acid)-functionalized antibodies was also demonstrated (Chakravarty et al. 2014; Domnanich et al. 2016) . 47 Sc nuclear reaction, however, too much of the long-lived 46 Sc was coproduced (Srivastava 2012 ). An alternative 47 Sc production route considers photonuclear reactions on enriched 48 Ti and 48 Ca targets, respectively (Yagi and Kondo 1977; Mamtimin et al. 2015; Rane et al. 2015; Starovoitova et al. 2015) . So far only the former route was studied in detail with enriched targets (Yagi and Kondo 1977) , while for the latter only natural target material was used for initial benchmark experiments. The aim of the present study was to optimize the parameters of the previously-reported production process for 47 Sc from enriched 46 Ca targets (Müller et al. 2014a ) in order to reproducibly obtain increased 47 Sc yields in a formulation allowing direct preclinical application after radiolabeling and to compare it with the method using 47 Ti as target material. 47 Sc labeling experiments with DOTANOC were performed as part of the quality control. In the second part of the study the stability of 47 Sc-labeled DOTANOC was investigated and SPECT/CT imaging studies were performed in tumor-bearing mice to compare the performance of 47 Sc-DOTANOC with the previously obtained PET images of the 44 Sc-labeled counterpart. Moreover, comparison of SPECT images obtained with mice injected with 177 Lu-DOTANOC were also performed. Ti metal and used as target material for fast neutron irradiation. Prior to irradiation, a precursory scan for trace metals by ICP-OES (Perkin Elmer Optima 3000) was performed.
Methods
Chemicals
The chemical separation of Sc from Ca was performed on a N,N,N' ,N'-tetra-n-octyldiglycolamide, non-branched resin (DGA, particle size 50-100 μm, TrisKem International, France). SCX cation exchange cartridges (100 mg Bond Elut SCX, particle size 40 μm, Agilent Technologies Inc., USA) or DGA extraction chromatographic resin were used for the preconcentration of Sc. Chemical separations were performed with MilliQ water, hydrochloric acid (HCl, 30% Suprapur, Merck KGaA, Germany) and sodium chloride (NaCl, Trace Select, ≥99.999%, Fluka Analytical, Germany). For the 47 TiO 2 reduction process, calcium hydride (CaH 2 , metals basis, Mg <1%, Alfa Aesar, Germany), argon (Ar, 99.9999%, Linde, Germany) and acetic acid (CH 3 COOH, 100% Suprapur, Merck KGaA, Germany) were used. Nitric acid (HNO 3 , 65% Suprapur, Merck KGaA, Germany) was required for the preparation of the 46 Ca targets. DOTANOC acetate was obtained from ABX GmbH, advanced biochemical compounds, Germany.
Production of 47
Sc from enriched 47 Ti
The reduction of 47 TiO 2 was performed at Helmholtz Center for Heavy Ion Research (GSI) in Darmstadt as described elsewhere (Lommel et al. 2014) . Briefly, the enriched 47 TiO 2 was combined with 40% surplus of calcium hydride and the reduction process was performed under constant argon flow at 900°C for 1 h. Dilute acetic acid was used for the isolation of the reduced 47 Ti metal from the co-produced calcium oxide.
To prepare the targets, 0.6-19.9 mg reduced 47 Ti powder was placed in a quartz glass ampoule (Suprasil, Heraeus, Germany) and sealed. The targets were irradiated with neutrons at the spallation-induced neutron source, SINQ, at Paul Scherrer Institut (PSI) at a fast neutron flux (>1 MeV) of 3.3-3.5 × 10 11 n cm −2 s −1 for 1.5-18.9 days and in the BR2 reactor at SCK.CEN, Mol, Belgium in a reflector channel at a fast neutron flux (>1 MeV) of 5.7 × 10 13 n cm −2 s −1 for 7 days. 47 Sc was formed via the 47 Ti(n,p) 47 Sc nuclear reaction with fast neutrons. Ca) transferred into a quartz glass ampoule, evaporated to dryness and sealed. , for 4 to 11 days, and at the BR2 reactor at SCK.CEN, Mol, Belgium at a thermal neutron flux of 3.2 × 10 14 n cm −2 s −1 for 7 days, respectively. The irradiated 46 Ca ampoules were delivered to PSI several days post-irradiation (2.6-12.4 d) and the 47 Sc separation was performed immediately, similarly to previously reported (Müller et al. 2014a) . Each ampoule was transferred into a hot cell and the glass surface was cleaned twice with~20 mL 1.0 M HCl and rinsed twice with~20 mL MilliQ water. The crushing of the quartz glass ampoule was performed within a plastic target tube in a separate hot cell. Subsequently, the target tube containing the crushed ampoule was attached to the separation panel with the aid of manipulators. The design of the separation panel, including the adaptation of its operation inside the hot cell, was a crucial part of the method development (Fig. 2) . The 46 Ca(NO 3 ) 2 (~10-25 mg) from the ampoule was dissolved in 4 mL 3.0 M HCl and transferred from the target tube to the reaction vessel. A system of syringes, peristaltic pumps and three-way valves (see schematic of the panel in Fig. 2 ) was used to transfer the reagents from outside into the hot cell. To ensure complete dissolution of the target material, the solution was pumped from the target tube to the reaction vial and back several times. The solution was loaded on a pre-conditioned DGA column (1 mL cartridge filled with 50-70 mg of DGA resin). A second rinse cycle of the crushed glass ampoule with 2.5 mL 3.0 M HCl ensured collection of final traces of the 47 Sc activity, which were subsequently sorbed onto the DGA resin column. Radioactivity detection probes were attached in the vicinity of the target tube and the DGA column to follow the transfer of the 47 Sc radioactivity. Further application of 2 mL 3.0 M HCl removed the stable 46 Ca and radioactive 47 Ca from the DGA resin. The entire Ca-containing effluent was collected in a separate vessel and kept for consecutive separation of further in-growing 47 Sc from the decaying 47 Ca. The sorbed 47 Sc was eluted from the resin column with 4 mL 0.1 M HCl and sorbed on a second column containing SCX cation exchange resin (Method A). Alternately, the 47 Sc-containing eluate was collected, acidified to yield a 3.0 M HCl solution and sorbed on a second, smaller DGA resin column (1 mL cartridge filled with 20-25 mg DGA resin) at a slow flow rate of~0.3 mL/min (Method B), as described by Domnanich et al. (Domnanich et al. 2016 
Radionuclidic purity
To identify the nuclide inventory of the samples, γ-ray spectrometry with an N-type high-purity germanium (HPGe) coaxial detector (EURISYS MESURES, France) and the Ortec InterWinner 7.1 software were employed. The aliquot of 47 Sc eluate was in the range of 3-15 MBq, while the entire neutron irradiated glass ampoules containing the 47 Ti were used for the measurements. The counting time was determined by ensuring the measurement error was <4%. To determine small activities of long-lived radionuclidic impurities, γ-spectrometry measurements of the same samples were performed with an extensive counting time several days post-irradiation. In vivo experiments were approved by the local veterinarian department and conducted in accordance with the Swiss law of animal protection. Female, athymic nude mice (CD-1 nude) at the age of 5-6 weeks were obtained from Charles River Laboratories, Sulzfeld, Germany. AR42J cells (rat exocrine pancreatic tumor cells, European Collection of Cell Cultures ECACC, Salisbury, U.K.) were suspended in PBS (5 × 10 6 cells in 100 μL) and subcutaneously inoculated on each shoulder. SPECT/CT experiments were performed about 2 weeks after tumor cell inoculation, when the tumor reached a size of about 400 mm 3 .
Imaging studies were performed using a small-animal SPECT camera (NanoSPECT/CT™, Mediso Medical Imaging Systems, Budapest, Hungary) as previously reported (Müller et al. 2014b ). The energy peaks for the camera were set at 159.4 keV (± 10%) for the scans with 47 Sc and 56.1 keV (± 10%), 112.9 keV (± 10%) and 208.4 keV (± 10%) for the scans with 177 Lu. SPECT/CT scans were followed by CT scans. The images were acquired using Nucline Software (version 1.02, Bioscan Inc., Poway, California, US). The reconstruction was performed iteratively with HiSPECT software (version 1.4.3049, Scivis GmbH, Göttin-gen, Germany). SPECT and CT data were automatically co-registered and the fused datasets were analyzed with the VivoQuant post-processing software (version 2.50, inviCRO Imaging Services and Software, Boston, USA).
The mice were injected intravenously with 47 Sc-DOTANOC (12 MBq, 1.2 nmol, 100 μL) and 177 Lu-DOTANOC (40 MBq, 1.2 nmol, 100 μL), respectively. The in vivo SPECT/CT scans of 35 min duration were acquired 3 h after injection of 47 Sc-DOTA-NOC. During the scans, the mice were anesthetized by inhalation of a mixture of isoflurane and oxygen. Post-mortem scans of 1.3-3.5 h were performed 6 h after injection of 47 Sc-and 177 Lu-DOTANOC. The SPECT acquisitions were performed in such a manner to obtain the same total number of counts for each scan.
Results
Production of 47 Sc from
47
Ti via the (n,p) reaction Ti and fast neutron flux into consideration. γ-spectrometry measurements of the neutron-irradiated 47 Ti ampoules revealed that, other than 47 Sc, the long-lived radionuclidic impurity 46 Sc was formed. The amount of generated 46 Sc was influenced by the irradiation period and the neutron energy (Bokhari et al. 2010; Zerkin 2016 ) and ranged from 3.8 to 11.5% 46 Sc/for the irradiations at SINQ (Additional file 1: Figure S3 ). Considerably less 46 Sc (0.05%) was produced by the irradiation at the BR2 reactor, however. In view of the high percentage of co-produced 46 Sc and the relatively low 47 Sc production yield at both facilities, the production of sufficiently high 47 Sc activities for radiopharmaceutical applications was not considered feasible and, thus, chemical isolation of 47 Sc from neutron irradiated (summarized in Table 3 ).
Sc is formed during the irradiation but also, however, for some time after the end of irradiation by the decay of 47 Ca. This implies that both the irradiation time (t irr = 7.0-11.0 d) and the elapsed post-irradiation time until the start of the separation (t wait = 3.0-12.5 d) are part of the yield-determining factors. The highest 47 Sc activities under the applied irradiation conditions become accessible at an optimal post irradiation waiting time (t opt ) and are represented as relative activity a( 47 Sc) opt in Table 3 . The measured relative 47 Sc activities (a( The measured relative 47 Sc activities (a( 47 Sc) meas ) of the irradiations ILL 1, ILL 5 and SCK.CEN are represented by single data points in Fig. 3 . After an optimal post irradiation waiting time (t opt ) of 2.8 days, the relative 47 Sc activity (a( 47 Sc) opt ) reaches the maximum with 0.43. The separations ILL 1 and ILL 5 were performed after waiting times of 6.7 and 6.8 days, resulting in lower relative 47 Sc activities of 0.34 and 0.37, respectively. The waiting time after the irradiation at SCK.CEN (3.0 days) is close to t opt , thus the obtained relative 47 Sc activity of 0.44 is comparable with the optimum value.
Separation of 47
Sc from
46
Ca and 47 Ca
After the ampoule was crushed, it was moved to the hot cell containing the production panel (Fig. 2) , where the target material was dissolved by repeated application of 6.5 mL 3.0 M HCl. The Sc and 47 Ca at an irradiation period of 7.0 days (solid blue and red line) and their subsequent decay functions after the EOI (dashed blue and red line) are calculated for the respective irradiations only 1.5 ± 0.6% of the 47 Sc activity remained on the column. Using Method A, the solution was concentrated on the SCX cation exchange resin (used as the second column) and eluted with 700 μL 4.8 M NaCl/0.1 M HCl solution (pH 0-0.5), collecting 94.8 ± 2.1% of the total 47 47 Sc activity after an in-growth period of 5.6 days (Fig. 4) and, thus, enabled repeated separations. As a result of experimental conditions, separations were performed after an in-growth time of 3-7 days. The separation process was successfully repeated 2-4 times, until the eluted 47 Sc activity was~100 MBq.
Radionuclidic purity of 47 Sc produced from 46 Ca via (n,γ) reaction
The γ-ray spectrum of the neutron-irradiated 46 Ca target material (Additional file 1: Figure S2a ) showed, exclusively, the γ-lines of 47 Sc (159 keV) and the parent nuclide 47 Ca (489, 808 and 1297 keV). After chemical separation and concentration of 47 Sc on SCX resin (Method A), the radionuclidic purity of the final 47 Sc eluate was 99.6 ± 0.7%.
When the second DGA column (Method B) was used, the radionuclidic purity increased to 99.99 ± 0.03% (Additional file 1: Figure S2b ). The long-lived radionuclidic impurity 46 Sc was only present in the eluate obtained from the first separation at a maximum of 0.005% and could be only detected by performing long-term γ-spectrometry measurements several days post separation. The isolated 47 Sc which was generated by the decay of 47 Ca in the Ca-containing fraction did not contain any 46 Sc, due to its entire removal within the first separation. Radiolabeling and stability of 47 Sc labeled DOTANOC Radiolabeling of 47 Sc was reproducible at a specific activity of 10 MBq 47 Sc per nmol DOTANOC, with >96% radiochemical purity. Depending on the activity concentration of the 47 Sc solution, it was also possible to label at higher specific activity of up to 25 MBq/nmol. The stability of 47 Sc-labeled DOTANOC in PBS (pH 7.4) was investigated over a period of 3 days and compared to the stability of the 177 Lu-labeled analogue (Fig. 5) .
Directly after the radiosynthesis of 47 Sc with DOTANOC, the amount of intact radiolabeled product was 96.6-99.0% with less than 2% of radiolysis products visible as pre-peaks on the HPLC chromatogram. After 1 day at room temperature, the amount of intact radiolabeled 47 Sc-DOTANOC decreased to 81.3%, while 18.3% were subjected to radiolysis. Over the whole investigation period of 3 days, the percentage of radiolysis products increased to 44.4%, however, the amount of free 47 Sc was always below 2.1%.
The stability of 47 Sc-labeled DOTANOC was found to be comparable with the clinically-used analogue 177 Lu-DOTANOC. After 3 days, the amount of intact 47 Sc-DOTANOC (54.1%) was similar to the amount of intact 177 .
Imaging with 47 Sc-DOTANOC in comparison to 44 Sc-DOTANOC and 177 Lu-DOTANOC SPECT/CT experiments performed with AR42J tumor-bearing mice allowed excellent visualization of the accumulated 47 Sc-DOTANOC in tumor xenografts, which express the somatostatin receptor (Fig. 6a) . Activity accumulation was also observed in the kidneys, which was due to renal excretion of the radiopeptide. The SPECT/CT image obtained with 47 Sc-DOTANOC showed an equal activity distribution profile as was previously demonstrated by a PET/CT scan of an AR42J tumor-bearing mouse 3 h after injection of 44 Sc-DOTANOC (Fig. 6b) (Domnanich et al. 2016) .
To compare the image quality of 47 Sc with the clinically-employed 177 Lu, mice with AR42J tumors were injected with either 47 Lu-labeled DOTANOC and scanned 6 h after injection (Fig. 7) . Both images visualized the uptake of the radiopeptides in tumor xenografts located on each shoulder of the mouse and in the kidneys. Ti metal by ICP-OES. Only the elements determined at a concentration higher than the detection limit are listed below. (DOCX 415 kb) 
